We are live on
!
Find out more
NanoViricides
NNVC
NNVC
39 hedge funds and large institutions have $70.5M invested in NanoViricides in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,987% more capital invested
Capital invested by funds: $3.38M → $70.5M (+$67.1M)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
0.03% more ownership
Funds ownership: 0.3% → 0.34% (+0.03%)
11% less funds holding
Funds holding: 44 → 39 (-5)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
39
Holders Change
-5
Holders Change %
-11.36%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
+$1.23M |
| 2 |
BlackRock
New York
|
+$146K |
| 3 |
Renaissance Technologies
New York
|
+$43.8K |
| 4 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$12.8K |
| 5 |
Goldman Sachs
New York
|
+$10.4K |
Top Sellers
| 1 |
Fayez Sarofim & Co
Houston,
Texas
|
-$33.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$16K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$10K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.09K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.96K |
